Abstract
P-22 Frequency of dihydropyrimidine dehydrogenase (DPD) deficiency detection and adverse events in patients receiving fluoropyrimidine-based therapy in a pancreatic and biliary tract cancer cohort
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have